MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Large PACS/RIS Replacement Project Announced in Turkey

By MedImaging International staff writers
Posted on 08 Apr 2015
Print article
Image: The FujiFilm Synapse PACS (Photo courtesy of FujiFilm).
Image: The FujiFilm Synapse PACS (Photo courtesy of FujiFilm).
The Medical Park Group (Istanbul, Turkey) has concluded a five-year PACS/RIS replacement project for all 30 hospitals in the group.

The PACS system selected is the FujiFilm Europe (Duesseldorf, Germany) Synapse PACS and positions FujiFilm as the most widely used medical informatics vendor and global leader among PACS vendors.

The Synapse PACS provides radiologists with advanced visualization tools to assist radiologists, surgeons, and clinicians with diagnosis, pre-operative planning, and clinical decision support. The Synapse PACS Clinical Workflow Manager (CWM) is intended to enhance access to patient data, and improves the efficiency of the clinical reporting workflow. The Synapse PACS enables the archiving and distribution of image information from all modalities, uses next-generation Web technology, and Wavelet on-demand compression.

Yuksel Yazici, deputy director of the Biomedical Department at the Medical Park Group, said, “This supports us in our mission to provide qualified healthcare services to our international patients.”

Related Links:

FujiFilm Europe
Medical Park Group



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Pre-Op Planning Solution
Sectra 3D Trauma
New
Ultrasound System
P20 Elite
New
Ultrasound System
Voluson Signature 18

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more